A systematic review of the treatment and management of pre-eclampsia and eclampsia in Pakistan by Shaikh, Saleem & Mir, Ali M.
Population Council 
Knowledge Commons 
Reproductive Health Social and Behavioral Science Research (SBSR) 
2016 
A systematic review of the treatment and management of pre-
eclampsia and eclampsia in Pakistan 
Saleem Shaikh 
Population Council 
Ali M. Mir 
Population Council 
Follow this and additional works at: https://knowledgecommons.popcouncil.org/departments_sbsr-rh 
 Part of the Demography, Population, and Ecology Commons, Family, Life Course, and Society 
Commons, International Public Health Commons, Maternal and Child Health Commons, and the Medicine 
and Health Commons 
Recommended Citation 
Shaikh, Saleem and Ali M. Mir. 2016. "A systematic review of the treatment and management of pre-
eclampsia and eclampsia in Pakistan." Islamabad: Population Council. 
This Report is brought to you for free and open access by the Population Council. 
  
 
S
y
st
em
at
ic
 r
ev
ie
w
 
  
 
   
  
A SYSTEMATIC REVIEW OF 
THE TREATMENT AND 
MANAGEMENT OF PRE-
ECLAMPSIA AND 
ECLAMPSIA IN PAKISTAN 
 
 
 
 
 
       
Saleem Shaikh 
Ali Muhammad Mir 
October, 2016 
 
 
 
 2  © 2016 The Population Council, Inc.   
 
 
Introduction: 
Hypertensive disorders during pregnancy are important causes of severe morbidity, long-term 
disability, and death of both mothers and their babies. About 10 percent of the women experience 
increased blood pressure during pregnancy and less than 8 percent pregnancies get complicated by 
preeclampsia. Among the preeclampsia patients, about 10 percent develop severe preeclampsia and 
eclampsia. Globally, about 10-20 percent maternal deaths are associated with eclampsia1. The 
majority of deaths of mothers and their babies caused by severe preeclampsia and eclampsia (PE/E) 
are preventable through provision of timely and effective medical care.2 
Pre-eclampsia is a multi-system disorder of unknown etiology characterized by development of 
hypertension to the extent of 140/90 mmHg or more with proteinuria after 20th week of gestation in 
a previously normotensive and non-protein uric pregnant woman. Pre-eclampsia has been associated 
with intrauterine growth retardation, preterm birth, maternal and perinatal death. 
Globally, every day, more than 800 women, die from preventable complications related to 
pregnancy, childbirth and other causes, and 7,300 women experience a stillbirth (Lancet 
2016). About 10 percent women experience hypertensive disorders during pregnancy (Duley 
et al 2009; Steegers et al 2010). Preeclampsia, defined as hypertension with proteinuria 
during pregnancy, complicates 4–5 percent of pregnancies (Steegers EA et al 2010; Abalos E 
et al 2013; Arulkumaran N et al 2013).  In developing countries, a woman is seven times as 
likely as to develop preeclampsia than a woman in a developed country. From 10-25 percent 
of these cases will result in maternal death (WHO 2007). 
Pakistan Perspective 
Magnitude of the Problem (Maternal morbidity and mortality trends) 
Pakistan is one of the six countries that account for more than 50% of the world’s maternal 
deaths (Hogan et al. 2010). According to Population Council estimates, each year, nearly 8.6 
million women become pregnant in the country. Of these, 15%, i.e., 1.2 million women are 
likely to face obstetric complications (Sathar et al. 2013). Each year, there are nearly 14,000 
pregnancy-related deaths (PRDs), which means on average one maternal death occurs every 
40 minutes. Pakistan has also one of the highest neonatal mortality rates in the world at 55 
per 100,000 live births. In KP, the NMR is 41 per 1,000 live births.3 
                                                 
1 World Health Organization (WHO) Make Every Mother and Child Count. The World Health Report 2005. Geneva: World Health Organization. 
2 World Health Organization  WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. 2011, WHO. Geneva. 
3 National Institute of Population Studies: Pakistan Demographic and Health Survey 2012-13. Report; 2013.  URL: 
https://dhsprogram.com/pubs/pdf/FR290/FR290.pdf   
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The maternal mortality ratio in Pakistan is estimated to be 276 per 100,000 live births.  
Although this number ranges from about 227 deaths per 100,000 live births in Punjab 
province to 789 deaths per 100,000 live births in Baluchistan province.  Pakistan 
Demographic and Health Survey 2006-07 reported that amongst maternal deaths, eclampsia 
accounted for more than 12% of direct maternal deaths (PDHS 2006-07).4 More recently, 
Population Council carried out a provincial level study to estimate MMR of Punjab province by 
using a community based informants’ network technique that is developed by the University 
of Aberdeen, UK. The study found that slightly more than a quarter of the deaths had occurred 
due to pregnancy-induced hypertension i.e. eclampsia (Population Council 2015).5   
The last MMR estimate for the country was based on the Pakistan Demographic and Health 
Survey 2006-07 (NIPS 2008) that has not been since updated. The survey was able to provide 
provincially representative estimates of maternal mortality. The current estimates available 
are based on projections with very wide levels of uncertainty. For instance, the Global Burden 
of Diseases (GBD) estimates the 2014 MMR for Pakistan at 401 per 100,000 live births with 
uncertainty between 233 and 560.5  
Initiatives taken by Pakistan 
The Government of Pakistan has, in recent years, initiated a number of major projects to 
improve maternal health outcomes in the country. Several important initiatives have also been 
launched to address the lack of maternal healthcare. However, updated maternal mortality 
estimates, especially at the provincial and district levels, are required to monitor and evaluate 
existing maternal, neonatal and child health (MNCH) programs; to introduce greater 
accountability; and to plan new initiatives. Apart from updating numbers, it is also important 
from a programmatic perspective that the underlying causes of maternal mortality be well 
understood. This information will also help in advocacy efforts to increase awareness about 
maternal health issues among the public, and increase the focus of policymakers on this 
neglected area, thereby maintaining pressure towards achieving the new Sustainable 
Development Goals (SDGs) by 2030.  
While the MMR is accepted as an important development indicator at the international and 
national levels, the range of simple, reliable and feasible methods for measuring maternal 
mortality is still limited, especially in developing countries. Maternal mortality is difficult to 
measure for a number of reasons. First, maternal death is a rare event and difficult to capture, 
                                                 
4 Pakistan Demographic and Health Survey 2006-07 
5 Kassebaum NJ et al. Global, regional and national levels and causes of maternal mortality during 1990–2013: a systematic analysis for the Global Burden 
of Disease Study 2013. Lancet; 2014. 13; 384 (9947):980-1004. 
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so large sample sizes are required for estimates to be reliable. For the same reason, 
measuring maternal mortality is also expensive. Secondly, at present there is no standard 
method that can be universally applied for measuring mortality; while various techniques have 
already been proposed or used to estimate maternal mortality in Pakistan, each has its 
limitations. 
Ideally a vital registration system is the most accurate way of estimating maternal mortality, 
provided the system includes questions on cause of death and deaths are fully recorded. In 
Pakistan the vital registration system is still in the process of development and there is no 
provision for mandatory registration of deaths. Including mortality questions in the census 
questionnaire is a potentially comprehensive alternative method for measuring maternal 
deaths. However, this question has yet not been included in Pakistan, and would require 
considerable training of enumerators/interviewers to ensure a full count.  
Many countries with deficient vital registration, including Pakistan, have used indirect 
techniques to generate maternal mortality estimates, such as conducting household surveys—
the next best option to vital registration. However, to measure maternal mortality, household 
surveys must have a large sample size and they are therefore expensive undertakings, not 
easy to repeat regularly.  
The indirect sisterhood method, which can be included in surveys with relatively smaller 
samples, uses reports by adults about aggregate numbers of surviving and deceased sisters, 
with additional questions related to the timing of death. This method identifies PRDs but tends 
to underestimate overall mortality because of inherent biases in data collection. More 
recently, direct sibling based methods have been introduced that provide all information 
required to estimate pregnancy-related mortality, including fertility, and also provide 
estimates of all female and male causes of mortality between the ages of 15 and 50. However, 
they are at best able to produce national level estimates, since they generate large sampling 
errors.  
Reproductive age mortality studies (RAMOS) were considered in the past as the gold standard 
for measuring maternal mortality. They involve systematic efforts to combine data on maternal 
deaths from multiple sources including vital registration, medical records, traditional birth 
attendants (TBAs), graveyard records, and verbal autopsies. RAMOS allow for important data 
collection on avoidable causes of deaths both at home and at the facility. However, these 
studies are complex, expensive, labor-intensive and largely applicable in settings with at least 
60% completeness of reporting of adult female deaths in vital registration. Moreover, they do 
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not provide a number of births for estimating the MMR and have rarely been carried out at a 
national level except in Egypt, Honduras and Guatemala.6,7 
There is lack of information on context-specific health system barriers that prevent optimal 
use of the lifesaving medicine (magnesium sulfate) in Pakistan. Recent empirical evidence 
generated by a study, carried out in Pakistan, found that while international recommendations 
on MgSO4 have been adequately translated in national policies in Pakistan, the gap remains 
in implementation of national policies into practice. In Pakistan, although efforts both at the 
national and sub-national levels are ongoing on the prevention and treatment of PE/E, results 
are generally suboptimal and program interventions remain uncoordinated and fragmented.  
In several countries, poor procurement and distribution systems are responsible for low 
availability of the drug. In Pakistan, a study found that a fragmented system for registration, 
procurement and distribution was at the source of the low use of magnesium sulfate even 
though policies were all aligned with international standards (Bigdeli et al., 2013). 
To fully appreciate the enormity of the problem at country level, we conducted a systematic 
review of published papers on PE/E in Pakistan from 2005-2015 in order to understand the 
key challenges, gaps and interventions related to the prevention and treatment of pre-
eclampsia and eclampsia. 
In recent years, the need for more precise sub- national estimates has increased. Post 
devolution after the 18th Constitutional Amendment, the provincial health departments are 
responsible for identifying priorities and developing provincial policies. Districts have also 
been empowered to develop their own health plans and seek the required allocation of 
resources from the district administration. The availability of reliable MMR estimates at both 
provincial and district level is essential for planning, monitoring, and evaluating maternal 
healthcare interventions.  
Material & Methods: 
We searched PubMed; Google Scholar; Medline/POPLINE; Science Direct; Cochrane; World Health 
Organization Library Information System (WHOLIS) and all databases available through EBSCO Host of 
original articles published between January 2000 and June 2015. 
                                                 
6 World Bank, Koblinsky M. Editor, Reducing Maternal Mortality. Learning from Bolivia, China, Egypt, Honduras, Indonesia, 
Jamaica, and Zimbabwe. Human Development Network, Health, Nutrition, and Population Series. The World Bank, Washington 
D.C. 2003 
7 Abouzahr C. Critical issues in safe motherhood, 110- 134, Geneva, WHO, 1999. 
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Inclusion criteria 
The overall selection criteria for this literature review were set in line with the study objectives of 
Landscape analysis on prevention and management of Preeclampsia/Eclampsia in Pakistan. Inclusion 
criteria of the literature include: studies published between 2000 and 2015, publication in English 
and peer reviewed and publications should have a focus on trials on preeclampsia, eclampsia, 
hypertension during pregnancy, use of loading dose of MgSO4 during SPE/E, the use of Aspirin 
prophylaxis for pregnant women at risk of developing PE/E, use of antihypertensive during pregnancy 
period, and use of loading dose of MgSO4 at the community/PHC level.  
This systematic literature review was conducted in three phases to collect, organize and analyze the 
published literature on pre-eclampsia and eclampsia in Pakistan between 2000 and 2015.  
Exclusion Criteria 
Documents older than 2000 were not included in the review. Moreover documents which did not 
directly discuss the objective of the review were also excluded. In addition to this, some documents 
had too small sample size and some were not discussing PE/E in detail, these were also excluded. 
Phase I: Title & abstract Screening 
During the phase one  two independent reviewers conducted title and abstract screening to determine 
that abstracts should be included or excluded in the next phase of the review. Abstracts were excluded 
if they were: 1) Not about Pakistan, 2) Not related to pregnancy; (for example: abstracts about male 
subjects and abstracts that discussed hypertension but not in pregnancy were excluded) 3) Not related 
to PE/E or associated risk factors, symptoms, or complications.  
PHASE II: Review of Complete Articles 
In the second phase, the two reviewers read the full text of the articles to determine their relevance 
and eliminated any papers that were based on data collected prior to 2000.  
PHASE III: Analysis 
Finally, the remaining articles were sorted into four types of papers—based on the main topic of 
each—that were found during the systematic review. 
1. Descriptive Papers: case reviews, project reports, literature reviews etc. 
2. Potential risk factors for pre-eclampsia and eclampsia 
3. Other health outcomes associated with pre-eclampsia and eclampsia 
4. Intervention: dosage or training/task-shifting 
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RESULTS 
After being screened as the most relevant documents 226 Abstracts were selected and 
reviewed. 11766 articles were excluded from the review. The detail is as under:- 
A total of 11,766 searches were made in the following websites:-Pubmed, Cochrane, 
Science Direct, Popline and Wiley Online Library. 
Google emerged with 85,900 searches of Eclampsia and 69, 100 searches of Pre-eclampsia 
in Pakistan. However it was not possible to peruse all documents thoroughly, therefore 
selected study was made of the most relevant documents. 
The most relevant data was found in 226 reports of these websites.  
Figure 1: Flow Diagram of Systematic Review Methods and Results 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Database Searches 
(excluding duplicates, 
non-English and 
irrelevant) 
(n=11766) 
 (n=926) 
 (n=236) 
Phase I: 10840 
excluded after review of 
titles and abstracts 
using Phase I criteria 
Phase II: 690 using pre-
2005 data excluded 
after review of full text 
Full text not available  
(n=10) 
Phase III: remaining 
papers sorted into 
four ‘types’ (n=226) 
Descriptive: case 
reviews, project 
reports, literature 
reviews etc. 
(n=147) 
Potential risk 
factors for PE/E 
(n=20) 
Other health 
outcomes 
associated with 
PE/E 
(n=33) 
Intervention: 
dosage or 
training/task-
shifting (n=26) 
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Rating 
Rating of the documents was set as under:- 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
High  
Documents which showed causes of PE/E were given 
high consideration   
Medium 
Documents which were outcome based were 
considered to be as medium 
Low 
Documents which had no comparison or control group 
studies were regarded as low. 
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Risk Factors 
The reviewed literature highlights different risk factors for developing PE/E. According to three studies, 
pre-eclampsia occurs as a complication of pregnancy while Eclampsia occurs only as complication of 
Pre-eclampsia. Pre-eclampsia is most often seen in first pregnancy, teen age pregnancy or 40 years 
above pregnancy. It is a common pregnancy associated disorder especially in primigravida and 
teenagers [1, 2, 3]. Nulliparity, Multiparty/Multiple pregnancies and twin pregnancies also cause pre-
eclampsia as per five other cross sectional research studies [4,5,6,7,8]. 
According to Cross-sectional observational studies, pregnancy induced hypertension the leading risk 
factor for developing Pre-eclampsia is also found in metformin treated groups [9,10]. The frequency 
of presence of Breast Arterial Calcifications-BAC on mammography is also associated with 
systemic hypertension and higher age [11]. The risk for developing Pre-eclampsia was seen to be 
increased, with an interval of 10 years or more, from the previous pregnancy.  
The assessment studies show that development of preeclampsia is associated with gestational 
diabetes pre-gestational diabetes, family history of hypertension, chronic hypertension, raised body 
mass index before pregnancy or at booking, mental stress during pregnancy, autoimmune disease, 
renal disease, fetal malformation and use of anti-depressive. Insulin dependent diabetes (IDDM) and 
Antiphospholipid syndrome also serve as risk factors for pre-eclampsia [12,13,14,15]. It also occurs 
due to food intake practices, food group consumption, and avoidance of any food, craving, aversion to 
any sort of food and/or non-consumption of adequate food [8]. Two more descriptive and prospective 
studies show that other risk factors leading towards pre-eclampsia are Doppler abnormalities & 
biomarkers [14], Amniotic Fluid Index [16] and parity [17]. 
In addition to the above, lipid metabolism, increased triglycerides levels along with decreased HDL-
cholesterol levels and delayed triglycerides clearance are also associated with the development of 
preeclampsia [17]. Similarly, two facility based research studies show that raised levels of serum 
bilirubin and liver enzymes ALT, AST and ALK/HELLP Syndrome are a cause in women with Pre-
eclampsia [18, 19].  
Six cross sectional and case studies conducted at health facilities show that other than the medicinal 
ones, there are some other potential risk factors for developing PE/E. These are poverty [20, 21, 22, 
23, 24, 25] illiteracy, low household income, unemployment, depressions, stress and gender 
inequality in Pakistan [26].  
Outcomes of PE/E  
Pakistan along with six other developing countries contributes to 50% of world’s maternal deaths. 
Globally, maternal death occurs during childbirth in 11-17% cases while 50-71% deaths occur in the 
postpartum period. Majority of these deaths are avoidable [26].  
Hypertensive disorders of pregnancy are a major cause of maternal and perinatal mortality and 
morbidity [25, 27,]. In Pakistan, its incidence and related mortality are high due to lack of adequate 
antenatal care and awareness. [28, 29, 30].  
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There are severe and frequent pathological changes in preeclampsia and eclampsia cases [31]. The 
adverse effects of PE/E include edema, headache, seizure, and death [28, 32, 33, 34]. The other 
health outcomes of PE/E include intrauterine growth restriction and still birth [35, 36, 37, 38, 39, 40, 
41], congenital anomalies, haemorrhage [42, 43, 44], Breast Arterial Calcifications, fibrinoid necrosis 
& hyalinization in placentae [45], morphology of placenta [46, 47] and Acute Kidney Injury-AKI [48]. 
Acute Kidney Injury-AKI is a frequently occurring complication in developing countries which ranges 
from 4% to 36%. In India and Pakistan, pregnancy-related AKI occurs mainly during the first trimester. 
These are related to severe states of sepsis. In Morocco, AKI occurs mainly in the third trimester in a 
context of hypertensive disorders. Total recovery of renal function depends on early and appropriate 
diagnosis and treatment. Prevention is the best strategy in this regard [48]. 
In addition to the above, in a number of cross-sectional studies it was estimated that pregnancy related 
Acute Renal Failure-ARF is the most common outcomes of PE/E and is a dangerous complication 
of pregnancy which carries very high mortality and morbidity [49, 50, 44, 51, 52, 53].  
With regards to other outcomes of PE/E, there is a significant clinical correlation between pregnancy-
induced hypertension, abruptio placentae [54, 55, 56] and proteinuria [57]. (A patient's eight and/or 
12-hour urine total protein values correlate with the 24-hour value to confirm the diagnosis of 
preeclampsia). 
Exposure to PE/E also leads to raised Serum Bilirubin and Liver Enzymes/HELLP Syndrome [18], 
peripheral arterial disease [58], low APGAR score8, Intra-uterine Death, low birth weight and perinatal 
death [59, 60]. Moreover, there are higher levels of serum leptin and higher levels of homocysteine in 
pregnancies complicated by pre-eclampsia and eclampsia [61]. 
In the same context, increased BMI [62], Renal, Cortical Necrosis [63] and elevated plasma leptin 
concentration appear to be a marker of pre-eclampsia independently or along with other parameters 
of pre-eclampsia [64]. In addition to these, loss of vision (Blurry vision and flashing lights, and floaters) 
are the other outcomes of eclampsia [65]. The literature also shows that there is strong association 
between preterm abruption and pre-eclampsia [66].  
PE/E ends up in delivery/pre-term delivery which is mainly Caesarian. A study was conducted in 2005 
[67] in Peshawar Pakistan. The objective of this study was to determine the rate and 
clinical indications for emergency and elective caesarean section. The study shows that most of the 
caesarean sections were emergency caesarean sections. The rate of caesarean section was only 
slightly higher than recommended by the WHO (Naeem, 2015). Out of 22% caesarean sections 6% 
were due to pregnancy induced hypertension. Maternal morbidity in emergency versus elective 
caesarean section is significantly higher [68]. New-born resuscitation is required in such kind of high 
risk pregnancies and personnel trained in newborn resuscitation should be available at the time of 
delivery [69].  
                                                 
8 Virginia Apgar invented the Apgar score in 1952 as a method to quickly summarize the health of newborn children 
through weight measurement after birth. 
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Evidences from Cases 
Malignant ovarian germ cell tumors at a tertiary care setting in Pakistan were studied [70] to see the 
frequency of placental infarcts in hypertensive preterm pregnancies and its effects on foetal 
outcomes (Hanan, 2015). Case records of 66 patients from 1994-2007 with MOGCT were reviewed. 
Findings highlight that histologically, dysgerminoma was the most common diagnosis followed by 
teratoma, yolk sac tumor, mixed germ cell tumor and embryonal carcinoma. The latter was found only 
in one patient. Median follow-up was 48 months. All patients underwent initial surgery. Fertility sparing 
procedures were performed in 75% patients. 58% patients achieved complete remission while 27% 
had progressive disease. 11% patients relapsed, all within first 3 years. Sixteen (88%) of stage I while 
only 4 (26.6%) of stage IV patients were alive at median follow-up (Hanan, 2015). 
A case study conducted to assess maternal and perinatal outcome in nulliparious women complicated 
with pregnancy hypertension [71 shows that there were no significant differences in maternal age, 
menstruation condition, delivery mode, placental detachment rate between the studied groups. 
Gestational age was significantly lower in the case group, especially in severe preeclampsia subgroup. 
Serum creatinine level more than 1.2 mg/dl was significantly higher in mild and severe preeclampsia 
groups. Significant differences were found in neonatal APGAR, need of resuscitation, NICU admission, 
birth weight and length, LBW and intrauterine growth retardation between the studied groups. 
Detection  
The severity of PE/E can be avoided through early/timely detection of the disease. Correct diagnosis 
and timely intervention can decrease the risk of maternal and perinatal mortality owing to PE/E.  
Factors like gestational diabetes, pre-gestational diabetes, family history of hypertension and mental 
stress during pregnancy can be used as a screening tool for pre-eclampsia prediction to timely 
diagnose and monitor women likely to develop preeclampsia before the onset of disease. This would 
facilitate timely interventions and ensure better maternal and fetal outcomes [1, 93]. 
PE can be predicted in primiparas in the early part of second trimester with serum levels of sFlt-19 and 
in the later part of second trimester with serum levels of Placental Growth Factor-PlGF10 [94]. As early 
diagnosis [48, 95, 72, 96] can lead to early treatment, it is utmost necessary to diagnose early for 
which routine antenatal check- up is a crucially important strategy. 
In addition to the above, imaging also plays a primary role in the diagnosis of cerebral venous sinus 
thrombosis because the clinical picture of CVST is non-specific and highly variable [97]. Clinical 
presentation of the patient is most important in diagnosing viral encephalitis in postnatal women 
especially when patient presents with fever, altered sensorium and convulsions [98]. 
                                                 
9 Soluble fms-like tyrosine kinase-1 (sFlt-1 or sVEGFR-1) is a tyrosine kinase protein that disables proteins that 
cause blood vessel growth. 
10 Placental growth factor 
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Management of Pre-eclampsia 
History 
 History of pre-eclampsia/eclampsia in previous pregnancy 
 History of pre-eclampsia/eclampsia in first degree relative 
 History of risk factors 
 
Examination 
 Proper antenatal blood pressure record 
 Early recognition of pre-eclampsia which is often symptomless 
 Awareness of the serious nature if blood pressure is associated with proteinuria 
Referral 
 Adherence to agreed guidelines for admission to hospital and investigations 
Treatment 
 Agreed guidelines for the use of anti-hypertensive 
 Agreed guidelines for the use of anti-convulsants therapy where preference should be 
MgSO4 
 Delivery to prevent serious maternal and foetal complications 
Follow-up 
 Postnatal follow-up 
 Appropriate contraceptive advice 
During home deliveries, postpartum administration of 600 μg oral misoprostol by trained TBAs s 
reduces the rate of PPH by 24% [107]. This medicine is easy in use and is of low cost.  Misoprostol 
can reduce PPH in community settings where the use of universal oxytocin prophylaxis is not feasible. 
With continuous training of TBAs on the use of Misoprostol with proper monitoring and evaluation 
system in place, maternal, perinatal and neonatal lives can be saved [106, 107]. 
Metformin is another effective and cheap treatment option for women with gestational diabetes with 
or without supplemental insulin [108, 109, 110]. During viral encephalitis in postnatal women who 
have convulsions, acyclovir therapy should immediately be started while making other investigations 
[98]. Moreover, peritoneal closure is beneficial in routine caesarean sections [111].  
Vitamin D supplementation in pregnancy can also improve maternal and neonatal outcomes [112]. 
Improvement in the management of hypertension and diagnosis of congenital anomalies [113] and 
improvement in maternity care services [114] is necessary to reduce still birth. 
With advancing pregnancy, intraocular pressure decreases. The mean intraocular pressures of third 
trimester hypertensive pregnant women are significantly higher from that of third trimester non-
hypertensive mothers. Therefore knowledge of Providers on the normal level of intraocular pressure 
in various stages of pregnancy may help glaucoma screeners [115]. 
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MgSO4 should be made available throughout the year in the provinces. Moreover prefilled standard 
dose should be purchased and prefilled dosage preparation should be available with the Providers 
[122]. Injections should be ready to use with no preparation required. 
There should be multiple suppliers of MgSO4. Its use should be enhanced by rewarding those who 
are using it. Moreover, advocacy should be made for the accessibility and use of magnesium sulfate 
in the country. 
 
Treatment 
Magnesium Sulphate (MgSO4) is the best way to treat PE/E than other anti-convulsants. Initial loading 
dose of magnesium sulphate not only prevents but also treats Eclampsia. MgSO4 is low-cost. Moreover 
subsequent follow up of MgSO4 is also easier. Therefore, MgSO4 is appropriate for use by PHC 
Providers. However, the dosage and duration of MgSO4 therapy should be decided after keeping in 
mind the local context [99]. 
MgSO4 acts as a vasodilator, with actions in the peripheral vasculature or the cerebrovasculature. It 
decreases peripheral vascular resistance and also relieves vasoconstriction. Moreover, MgSO4 also 
protects the blood-brain barrier and limits cerebral edema formation. It also acts through a central 
anticonvulsant action [100]. Use of MgSO4 is as under [101]:- 
Dosage of MgSO4 I/M loading dose 
10 gms (10 ml or 01 ampule) of MgSO4 Injection given as a loading dose (5gms in each 4 buttock I/M) 
and dilute this with 10 ml of normal saline and 2 % xylocaine injection i.e. total of 10 gms [101]. 
Loading Dose of MgSO4  
 A loading dose of 4 gms (8 ml of 10 ml vial) of MgSO4 in 50 ml of solution over 10 minutes 4 
by an intravenous infusion. 
 Followed by I/M Injection of 5gms (10 ml or 1 vial) of MgSO4 mixed with 1ml of 2% lignocaine 
injection first in one buttock and then the other making a total of 14gms. 
Maintenance dose of MgSO4  
 Maintenance dose of 5 gms (10 ml or 1 vial) of MgSO4 mixed with 2% lignocaine 1ml is 4 then 
is given 4 hourly I/M in alternate buttock for 24 hours (Pritchard regimen) after delivery. 
If seizures continue or recur:- 
 MgSO4 2 g I/V can be repeated when required. If this fails then diazepam 10 ml I/V or 4 
thiopentone 50 mg I/V. 
Monitoring of MgSO4 therapy 
 Once MgSO4 is given monitoring of the patient should be done every 10 minutes for first 4 2 
hours and then every 30 minutes by:- 
 
 Urine output (more than 25mls/ hour 
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 Knee jerk (should be present) 
 Respiratory rate (more than 16/ min) 
If either of these is disturbed MgSO4 should be stopped immediately.  Antidote is Calcium Gluconate 
Injection 10 ml is given slowly I/V over 10 minutes [101]. 
Magnesium Sulphate-MgSO4 is registered in Pakistan as the first line treatment of eclampsia and 
severe eclampsia. The medicine is also enlisted in National Essential Medicines List, Pakistan National 
Formulary and MNCH EmONC Training Manual [102]. 
There are certain clinical requirements for the use of magnesium sulfate, which include the availability 
of infusion pumps for I/V use, dosage preparation, availability of the antidote calcium gluconate and 
understanding the contra-indication to use especially alongside diazepam. Magnesium levels are not 
required routinely for its use. This clearly demonstrates that along with the formulation of clinical 
guidelines, procedures need to be in place at facility level with relevant staff trained and equipment 
available [102].  
Pakistan Perspective 
In Pakistan, 10 grams (10 ml or 01 ampule) of MgSO Injection is given as a loading dose (5gms in 
each 4 buttock I/M) and this is diluted with 10 ml of normal saline and 2 % xylocaine injection i.e. 
total of 10 grams is given. 
 
Loading Dose of MgSO4 
 
 A loading dose of 4 gms(8 ml of 10 ml vial) of MgSO in 50 ml of solution over 10 minutes 4 
 by an intravenous infusion 
 Followed by I/M Injection of 5gms (10 ml or 1 vial) of MgSO4 mixed with 1ml of 2% 
 lignocaine injection first in one buttock and then the other making a total of 14gms. 
 
Maintenance dose of MgSO4 
 
 Maintenance dose of 5 gms (10 ml or 1 vial) of MgSO mixed with 2% lignocaine 1ml is 
 then given 4 hourly I/M in alternate buttock for 24 hours (Pritchard regimen) after 
 delivery. 
 
If seizures continue or recur 
 
 MgSO 2 g I/V can be repeated when required. If this fails then diazepam 10 ml I/V or 4 
thiopentone 50 mg I/V 
 
Monitoring of MgSO therapy 4 
 
 Once MgSO is given monitoring of the patient should be done every 10 minutes for first  
2 hours and then every 30 minutes by: 
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o Urine output (more than 25mls/ hour) 
o Knee jerk (should be present) 
o Respiratory rate (more than 16/ min) 
 
If either of these is disturbed MgSO should be stopped immediately. 
Antidote is Calcium Gluconate Injection 10 ml given slowly I/V over 10 minutes. 
Challenges in the use of MgSO4: 
While international recommendations on MgSO4 have been adequately translated in national policies 
in Pakistan, gap remains in the implementation of national policies into practice. Barriers to access to 
and effective use of MgSO4 occur at health facility level where the medicine is not available and health 
staff is reluctant to use it. Low price of the medicine and the small market related to its narrow 
indications also act as disincentives for the effective marketing of MgSO4 [118]. Due to these reasons 
like in many other Low- and Middle-Income Countries, MgSO4 is enormously under-utilized in Pakistan. 
There are context-specific health system barriers that prevent optimal use of this life-saving medicine, 
which should be removed to enhance the use of MgSO4 [119]. 
Supply of MgSO4 is interrupted sometimes and provinces face shortage of the same. The preparation 
of its dosage is also difficult. Moreover there are misconceptions about its use among the senior 
Obstetricians. 
Other than medicinal one, to balance the timing of delivery of patients with pre-eclampsia before the 
onset of eclampsia is also a major challenge [120]. 
Magnesium sulfate is on WHO’s essential medicines list since 1996 and since 2003 which has 
specifically been included for the treatment of severe pre-eclampsia and eclampsia. If MgSO4 is used 
appropriately in Pakistan it can bring about a significant reduction in the maternal mortality and 
morbidity rates [121, 122].  
Strategies to reduce PE/E 
Short term, medium term and longer term Strategies need to be developed based on competency- 
based training and deployment and supervision of a cadre of skilled attendants for delivery at the 
community level. In addition upgrading of health care systems especially availability of emergency 
obstetric care is urgently required to overcome PE/E and maternal mortality related with it [123]. Thus 
continued efforts are needed to improve the availability and quality of Emergency Obstetric and 
Newborn Care through targeted skill-based training [124, 125] and provision of adequate drugs and 
equipment [124, 126]. There should be proper legislation for this [125].  
Maternal morbidity and mortality can be reduced through safe motherhood programs, provision of 
separate ICU services for critically ill obstetrical patients and early assessment & intervention through 
a team work approach involving obstetricians, Intensivists and Anesthetists [127]. Delivery of proper 
health care system and emergency obstetrical care facilities are vital for the early detection and proper 
management of PE/E. Provision of skilled care and timely management of complications can reduce 
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maternal mortality in our country [84]. With proper peripartum care, [128], complete utilization of 
medical treatment [70] and close monitoring in post-operative period [129] maternal mortality can be 
reduced. 
Long-term mobilization of social structure and governance is also needed to encourage maternal 
health awareness, hospital deliveries, and formal sector employment for employed mothers [130]. 
Providing balanced protein energy and multiple micronutrient supplements to pregnant women will 
reduce incidence of Intrauterine Growth Restriction -IUGR. Moreover, community-based intervention 
packages are among the most effective methods of reducing morbidity and mortality in mothers and 
children [131, 132]. Maternal and newborn care programs should be integrated in community settings 
through community health workers, self-help groups and health promotion groups. Community-based 
care should be scaled up through packages to be delivered by community-based workers [132]. 
Micronutrient malnutrition programs should be integrated in maternal, nutrition and antenatal care 
programs to maximize outcome [77]. Poverty alleviation and nutritional support programs can be 
launched for women of reproductive age and all these can also be packaged in the MNCH program 
[24]. 
Linkage of RHMNCH with other health and nutrition programs will bring effective results under 
maternal and newborn health and save from duplication of efforts and resources in interventions 
related to PE/E [133]. This will also enhance the efficiency of training, monitoring, and supervision of 
health care workers dealing with PE/E; it will also help families and communities to access and use 
health care services providing PE/E treatment easily [133]. Log books to document skill use during 
emergency obstetric care can be launched and used to measure outcome of PE/E programs and 
monitor the performance of health care workers and providers [134].  
The literature depicts that sustained investment in health care reforms [135], political will and 
partnerships to implement evidence-based PE/E interventions at scale [136], skilled care at facility 
level and household care at community level for improving maternal, newborn and child survival [137] 
are the best strategies to reduce PE/E in specific and maternal mortality as a whole. 
In addition to the above, it is crucially important to increase the accessibility of ANC services by 
extending facility working hours and making adjustments according to the convenience of clients in 
primary healthcare (PHC) facilities. The utilization of ANC services can also be enhanced through 
community awareness and gender empowerment for ANC decision making [72, 138,]. 
Depression is the leading cause of hypertension. To cope with depression during pregnancy, 
Gynaechologists and Psychiatrists should work together in managing such patients [4] so that it does 
not lead to hypertension. 
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Laboratory Services 
Elevated plasma leptin concentration appears to be a marker of pre-eclampsia independently or along 
with other parameters of pre-eclampsia. This can be used to reduce the severity of pre-eclampsia thus 
avoiding risk effects of pre-eclampsia to mother and foetus [116]. In addition to this, management 
and delivery of HELLP syndrome patients can be performed at tertiary care centres, where highly 
trained obstetrician, neonatal intensive care unit personnel and Multi-disciplinary facilities are 
available [117].  
Community- based Prevention 
PE/E can be prevented through routine antenatal examination, availability of health facilities at an 
ease of access and prompt referral to tertiary care hospital [5, 70, 71, 72]. In order to decrease the 
adverse outcome of eclampsia a community-based approach is needed to improve community health 
education, socioeconomic status and prenatal care [73]. In addition to this, delivery of proper health 
care system and emergency obstetrical care facilities are vital for the prevention of PE/E [73]. Maternal 
mortality can be reduced with proper peripartum care [29] and skilled care during pregnancy, 
childbirth, and postnatal period [74]. Assessment of blood lipids is also helpful in the prevention of 
complications in patients with pregnancy-induced hypertension.  
Vitamin -D deficiency and Pre-eclampsia are correlated, therefore, PE can be prevented by overcoming 
this deficiency and other micronutrient malnutrition [75, 76] like iron and folic acid [77]. Likewise 
calcium supplementation during pregnancy is associated with reduction in risk of gestational 
hypertensive disorders, pre-term birth and an increase in birth weight which can also be looked into 
for interventions aiming to prevent PE/E [78, 79, 80, 81]. However further research is needed to 
assess its benefit in detail [82]. 
In addition to this the creation of increased community demand for health services and increasing 
their uptake also can play a role in preventing PE/E and its outcomes including stillbirths [83]. Other 
potential socio-behavioral interventions include birth spacing, smoking cessation and indoor air 
pollution control, although the evidence for these is weak in the literature [83]. Mitigation of all risk 
factors identified for still birth and periodontal disease can prevent the outcome of PE/E. Infection 
control measures, syphilis screening & treatment and malaria prophylaxis in endemic areas are strong 
interventions for preventing antepartum still births. As still birth is preventable with high quality 
obstetric care, [84, 85] related interventions should be incorporated into antenatal care programs 
[86]. Basic and Comprehensive Emergency Obstetric Care are the effective interventions to reduce 
intrapartum stillbirths though a lot more needs to be done in this regard [87].  
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Facility - based Prevention 
PE/E can also be prevented through facility level interventions. Up-gradation of health facilities 
including tertiary level hospitals and deployment of senior, skilled and experienced personnel in the 
management of obstetrics emergencies can effectively reduce caesarean section rate and maternal 
morbidity & mortality. This would ultimately improve fetal outcome as well [48]. Moreover, community 
sensitization for early antenatal booking and provision of emergency obstetric care services at door 
step will also improve obstetric outcome [88]. 
Importance of Public Health initiatives 
Importance of public health interventions for preventing PE/E can also not be denied. Improving 
education, nutrition, and uniform implementation of obstetric care protocols are needed for better 
maternal and neonatal health in Pakistan [89]. Focus of attention should be there on regular ANC and 
follow up, Vitamin-A Supplementation and Calcium Supplementation, strengthened Referral to tertiary 
care hospitals and strengthening of the four interlinked health system elements i.e. human resources, 
access to, use and quality of services is essential though not sufficient strategies for the prevention of 
PE/E [90, 91]. 
Improving education, nutrition, and uniform implementation of obstetric care protocols are needed for 
better maternal and neonatal health in Pakistan [92]. Gender empowerment, decision making and 
provision of adequate drugs & equipment at health facilities are the best strategies to prevent or 
reduce PE/E.  
Procurement and Distribution:  
The medicine is procured by Ministry of National Health Services Regulation and Coordination. There 
is no budget allocated to the provinces whereas the medicine is directly procured by the provinces. 
Acquisition, storage and distribution of MgSO4 is done by Provincial Medical Store Depot who then 
supplies MgSO4 to Government hospital pharmacies and District Health Offices. Private hospitals buy 
MgSO4 from the open market. Grant is also given to specialized hospitals like Pakistan Institute of 
Medical Sciences to procure emergency medicines including MgSO4 independently. Procurement of 
this medicine depends on the demand of health department [102]. 
Other than MgSO4, use of low dose aspirin and low molecular weight heparin is safe in pregnancy and 
it improves foetal outcome in patients with recurrent pregnancy loss due to anti-phospholipids 
syndrome [103, 104, 105]. 
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Demand and Supply 
Demand  
According to a study conducted in 2010 (Hafeez, 2010) training and intervention was found to be 
extremely facilitative factor for the use of MG SO4 even in the non-teaching facilities. Most of the 
doctors found the dosage preparation to be the biggest barrier to the use of the medicine as they had 
to recall, calculate and prepare the dosage themselves [102]. 
Due to lack of training and non-inclusion of the use of MgSO4 in in-service training, there is lack of 
demand in health care providers with regards to MgSO4. Lack of community awareness is also another 
factor behind the low demand generation of the medicine.  
Supply  
Lack of demand is contributing to lack of supply. Before initiating any intervention to improve the 
management of eclampsia and severe eclampsia Pakistan a thorough understanding of the local 
context needs to be made. Pakistan is facing constraints in the utilization of MgSO4 due to lack of 
clinical guidelines, difficult dosage calculation of the medicine and lack of equipment, human 
resources and trainings. [102] 
MgSO4 needs to be made available to provinces throughout the year by having multiple suppliers. 
Moreover prefilled standard dose needs to be purchased to maximize its correct use. 
Health System Barriers in the use of MgSO4 in Pakistan 
Lack of procurement, lack of availability and inadequate and improper use of MgSO4 is the greatest 
barrier in the use of this medicine in Pakistan. Other common barriers are complex dosing regimens, 
a lack of product harmonization, low familiarity of the drug, and hesitation of health care providers to 
administer MgSO4 due to its perceived side effects, all of which limit its impact. Yet another barrier is 
delay in the administration of second dose in case of referral.  
Other than the above, lack of training is adversely affecting the treatment of PE/E. according to a study 
conducted in 2010 (Hafeez, 2010) some of the teaching hospitals were found to be using diazepam 
and MgSO4 together for admitted eclampsia patients. This was against the standard treatment 
guidelines and it was dangerous to use this medicine in such a way. Some of the staff working in the 
non-teaching settings had received EmNOC trainings by MNCH program which had enhanced their 
awareness on the use of MgSO4. However, the lower level hospitals providing maternal care were 
better equipped and were using MgSO4 injections for eclampsia.  
Community Review/Case Studies 
A Study Frequency and Impact of Hypertensive Disorders of Pregnancy [27] conducted in 2014 
(Parveen M. Aabidha, 2015) shows that total deliveries during study period were 2702. Out of 2702 
deliveries 150 (5.5%) mothers were hypertensive. Out of 150 hypertensive cases 30% were cases of 
gestational hypertension, 58% were cases of toxemia of pregnancy and 12% were cases of 
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chronic hypertension. Maternal age, gravida, parity was lowest in toxemia of pregnancy group. 
Commonest maternal complication was eclampsia (32%). There were 6 (4%) maternal deaths. 
Caesarean section was mode of delivery in 54% cases. Thus, hypertension disorders 
of pregnancy appear to be an important cause of maternal and perinatal mortality and morbidity 
(Parveen M. Aabidha, 2015). 
According to another case study [105] (Sultana, 2005) a total of 2100 admissions were made in the 
labor ward during this period and out of them 68 cases (3.23%) were of eclampsia. Out of them 28 
were primigravida, 14 multigravida and 26 grandmultigravidae. The seasonal frequency of cases was 
29.41% in winters, 42.64% in autumn, 19.11% in summers and 8.82% in spring. Out of these 11.76% 
cases were complicated with retro placental hemorrhage and the same number with aspiration 
pneumonia, while Cerebrovascular Accident (2.94%) Acute tubular necrosis (2.94%) and Disseminated 
intravascular clotting (4.4%) were also seen. Among the newborns prematurity was found to be the 
major cause of perinatal mortality. Eclampsia is a dreadful complication of Pre eclamptic Toxemia 
of pregnancy associated with high perinatal and maternal mortality. A qualitative and quantitative 
improvement in prenatal consultation should make it possible to reduce incidence of eclampsia 
measuring arterial blood pressure daily during antenatal period and for at least 14-days postpartum 
appears to be necessary for diagnosis and treatment for all cases of hypertension. 
Other case studies [1, 21, 40, 44, 52, 60, 69, 117, 141-153] illustrate the importance of surgical 
management of pheochromocytoma in second trimester of pregnancy to avoid catastrophic 
complications later in pregnancy, high rate of emergency caesarean sections than the elective ones 
and high prevalence of HCB & HBV among pregnant women etc.  
Some other papers [154-249] also deal with maternal and neonatal mortality, however the same is 
not specific to PE/E. 
Discussion 
Skilled based training of the health care providers is crucially important to improve emergency 
Obstetric and Newborn Care. Along with it continual training and skill-building of TBAs and community 
health workers is also essential. All should specifically be trained on how to screen pregnant mothers 
during ANC visits to detect signs of PE/E and how to administer MgSO4 to patients who are in need of 
anticonvulsant therapy. Before training, training need assessment should be conducted specifically to 
assess gaps in knowledge and practices.  
It is critically important to improve quality of care with regards to the management of PE/E in Pakistan 
by developing clinical operational guidelines/protocols. Since there is no endorsed guideline/protocol 
available at national, provincial or regional level, it is the dire need of time to do so. White Ribbon 
Alliance-WRA Pakistan has formulated Trainees’ Manual on the use of Magnesium Sulphate as a first 
line-treatment in severe Pre-eclampsia and Eclampsia, Pakistan11. These guidelines are for doctors 
                                                 
11 USE OF MAGNESIUM SULPHATE AS A FIRST LINE TREATMENT IN SEVERE PRE-ECLAMPSIA AND 
ECLAMPSIA-Trainees’ Manual for Health Care Professionals-White Ribbon Alliance and Research and Advocacy Fund-RAF Pakistan 
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working at primary, secondary and tertiary care health facilities. Chapter 5 of this manual illustrates 
Use of Magnesium Sulphate in detail.  
In addition to it WHO Recommendations for Prevention and treatment of Pre-eclampsia and Eclampsia 
are there which also highlight use of Magnesium Sulphate as an effective remedy for PE/E. After 
evidence, magnesium sulfate was found to be associated with significant reduction both statistically 
and clinically, in the risk of eclampsia by 59% as compared to placebo and other anticonvulsants. 
This shows need for enhanced use of magnesium sulphate for PE/E management with proper 
guidelines available.  
Along with an increase in ANC, skilled delivery, PNC, family planning and nutritional status of mothers 
would further improve the situation. Gender equality, women empowerment and livelihood programs 
are also not an exception.  
In order to understand the actual situation of PE/E in Pakistan it is important to adopt evidence-based 
approach and initiate community studies. Community studies through accurate, historical and 
contextual analysis of community health would enable to understand psycho-social, socio-cultural and 
socio-economic determinants of PE/E at one hand and barriers to address PE/E at the other. Through 
grass-root level Research (investigation and observation) at an extensive scale, actual situation can 
be understood along with adequacy of underway interventions, challenges/barriers and required 
reforms to prevent and cure PE/E in the country. Allocation of sufficient resources should be made 
under community studies in all PE/E related interventions therefore.  
Research Gaps 
None of the studies is adequately and specifically depicting barriers in the availability, preparation, 
use and follow up of MgSO4 for managing and treating PE/E in Pakistan. 
Likewise no study is adequately highlighting how to enhance the use of MgSO4 in Pakistan. Moreover 
adequate focus of all studies regarding the training of health care providers on the preparation and 
use of MgSO4 is also missing. The research studies have also not vigorously highlighted the 
importance of having national level clinical guidelines for the use of MgSO4.    
Gaps in the Knowledge Base  
Knowledge on the use of MgSO4 to treat PE/E is there as far as health care providers are concerned. 
However, use of MgSO4 is low. MgSO4 is critically under-utilized in Pakistan. There is a lack of 
information on context-specific health system barriers that prevents optimal use of this life-saving 
medicine in Pakistan. Future research needs to be made in this regard as only one paper under review 
is significantly highlighting these barriers. 
Likewise no paper is showing the impact of the use of MgSO4 so that the findings could be 
disseminated to all stakeholders to maximize the use of medicines. Only one study has shown reasons 
for the low use of this medicine in detail [122]. This paper has also described some guidelines on the 
preparation of this medicine [122].   
 22  © 2016 The Population Council, Inc.   
 
 
Similarly no study contains any guideline on the use of MgSO4 though a number of studies have 
identified the importance of guideline formulation. In the same context, no report significantly 
describes about frequency of MgSO4 utilization in the health facilities of Pakistan, causes of its low 
use, demand and supply side interventions of MgSO4, knowledge of health care providers and their 
willingness on the use of MgSO4, impact of MgSO4 usages (where this medicine has been and is being 
used), challenges and required reforms in the health care system to make this medicine well utilized. 
Therefore there are gaps in the evidence. 
There is a positive link between Vitamin D deficiencies and Preeclampsia. Vitamin D supplementation 
can reduce pre-eclampsia. However, further research needs to be conducted to establish this 
relationship.  
In addition to the above, literature is also highlighting research gaps and future research areas. Studies 
should be conducted to assess: excessive use of micronutrients during pregnancy [189], triage of 
preterm and growth restricted infants [131], benefits of calcium supplementation and aspirin to 
prevent still birth [82, examine clinical benefits of vitamin B6 supplementation in pregnancy and/or 
labour [177, 194], minimize newly recognized risk factors for stillbirth including periodontal [38], 
assess the effect of psychotic symptoms with seizure control [202] and assess differences in 
intraoperative and postoperative hemorrhage when misoprostol is compared to oxytocin [106]. 
Conclusion and Recommendations 
Key recommendations from the identified and reviewed literature are as under:- 
MgSO4 is still not in widespread use in Pakistan though it is the best treatment for the management 
of PE/E according to WHO. Future researches should explore the followings areas in detail: 
 Barriers to the availability of MgSO4 at all levels 
 How to scale up the use of MgSO4 in Pakistan 
 Formulation and use of national level clinical guidelines on the use of MgSO4 
 Inadequate training of health care providers on managing and treating PE/E   
 Inadequate training of health care providers on the preparation and use of MgO4 
 Cost effectiveness of MgSO4 
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